By Braden Campbell ( July 5, 2016, 12:16 PM EDT) -- Bristol-Myers Squibb Co. will pay as much as $520 million to boost its cancer therapy pipeline with the acquisition of Swedish drug developer Cormorant Pharmaceuticals in a deal guided by Kirkland & Ellis LLP, the global pharmaceutical giant said Tuesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.